Format

Send to

Choose Destination
Ned Tijdschr Geneeskd. 1999 Nov 20;143(47):2383-5.

[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].

[Article in Dutch]

Author information

1
Groningen University Institute for Drug Exploration (GUIDE)/Rijksuniversiteit, vakgroep Sociale Farmacie en Farmaco-epidemiologie. m.postma@farm.rug.nl

Abstract

The role of reinfection and the importance of partner treatment were added to a pharmacoeconomic model for the analysis of a GP-based opportunistic screening programme for Chlamydia trachomatis (CT) in sexually active women in Amsterdam. A favourable cost-effectiveness was found for partner treatment. Partner treatment was cost saving and overall net costs per major outcome averted by the screening programme were reduced by 40% or more due to partner treatment. From a pharmacoeconomic point of view partner treatment should be routinely provided in the framework of a CT screening programme for Amsterdam women.

PMID:
10590778
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center